Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes

Genes and Development

Volumn 19, Issue 8, 2005, Pages 903-918

  Darnell, Jennifer C ^a   Fraser, Claire E ^a   Mostovetsky, Olga ^a   Stefani, Giovanni ^a   Jones, Thomas A ^b   Eddy, Scan R ^a,b   Darnell, Robert B ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

FMRP; Fragile X mental retardation; KH domain; Kissing complex; Loop loop pseudoknot; Polyribosome; RNA

Indexed keywords

ASPARAGINE; FRAGILE X MENTAL RETARDATION PROTEIN; ISOLEUCINE; PROTEIN KH2; RNA; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; FRAGILE X SYNDROME; HUMAN; MENTAL DEFICIENCY; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; POLYSOME; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN RNA BINDING; PROTEIN TERTIARY STRUCTURE; TRANSLATION REGULATION;

AMINO ACID MOTIFS; ANIMALS; BASE PAIRING; BASE SEQUENCE; BLOTTING, WESTERN; CEREBRAL CORTEX; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE EXPRESSION REGULATION; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NERVE TISSUE PROTEINS; POLYRIBOSOMES; PROTEIN STRUCTURE, TERTIARY; RNA; RNA-BINDING PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 17444384228     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1276805     Document Type: Article

References (80)

1. Amarasinghe, A.K., MacDiarmid, R., Adams, M.D., and Rio, D.C. 2001. An in vitro-selected RNA-binding site for the KH domain protein PSI acts as a splicing inhibitor element. RNA 7: 1239-1253.
2. Antar, L.N., Afroz, R., Dictenberg, J.B., Carroll, R.C., and Bassell, G.J. 2004. Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses. J. Neurosci. 24: 2648-2655.
3. Argaman, L. and Altuvia, S. 2000. fhlA repression by OxyS RNA: Kissing complex formation at two sites results in a stable antisense-target RNA complex. J. Mol. Biol. 300: 1101-1112.
4. Bardoni, B., Schenck, A., and Mandel, J.L. 1999. A novel RNA-binding nuclear protein that interacts with the fragile X mental retardation (FMR1) protein. Hum. Mol. Genet. 8: 2557-2566.
5. Bartel, D.P. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
6. Braddock, D.T., Baber, J.L., Levens, D., and Clore, G.M. 2002a. Molecular basis of sequence-specific single-stranded DNA recognition by KH domains: Solution structure of a complex between hnRNP K KH3 and single-stranded DNA. EMBO J. 21: 3476-3485.
7. Braddock, D.T., Louis, J.M., Baber, J.L., Levens, D., and Clore, G.M. 2002b. Structure and dynamics of KH domains from FBP bound to single-stranded DNA. Nature 415: 1051-1056.
8. Brannvall, M., Mikkelsen, N.E., and Kirsebom, L.A. 2001. Monitoring the structure of Escherichia coli RNase P RNA in the presence of various divalent metal ions. Nucleic Acids Res. 29: 1426-1432.
9. Brosius, J. and Tiedge, H. 2001. Neuronal BC1 RNA: Intracellular transport and activity-dependent modulation. Results Probl. Cell Differ. 34: 129-138.
10. Brown, R.S., Hingerty, B.E., Dewan, J.C., and Klug, A. 1983. Pb(II)-catalysed cleavage of the sugar-phosphate backbone of yeast tRNAPhe-Implications for lead toxicity and self-splicing RNA. Nature 303: 543-546.
11. Brown, V., Jin, P., Ceman, S., Darnell, J.C., O'Donnell, W.T., Tenenbaum, S.A., Jin, X., Feng, Y., Wilkinson, K.D., Keene, J.D., et al. 2001. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in Fragile X Syndrome. Cell 107: 477-487.
12. Buckanovich, R.J. and Darnell, R.B. 1997. The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Mol. Cell. Biol. 17: 3194-3201.
13. Caudy, A.A., Myers, M., Hannon, G.J., and Hammond, S.M. 2002. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes & Dev. 16: 2491-2496.
14. Caudy, A.A., Retting, R.F., Hammond, S.M., Denli, A.M., Bathoorn, A.M., Tops, B.B., Silva, J.M., Myers, M.M., Hannon, G.J., and Plasterk, R.H. 2003. A micrococcal nuclease homologue in RNAi effector complexes. Nature 425: 411-414.
15. Ceman, S., Brown, V., and Warren, S.T. 1999. Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex. Mol. Cell. Biol. 19: 7925-7932.
16. Ceman, S., Nelson, R., and Warren, S.T. 2000. Identification of mouse YB1/p50 as a component of the FMRP-associated mRNP particle. Biochem. Biophys. Res. Commun. 279: 904-908.
17. Corbin, F., Bouillon, M., Fortin, A., Morin, S., Rousseau, F., and Khandjian, E.W. 1997. The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes. Hum. Mol. Genet. 6: 1465-1472.
18. Darnell, J.C., Jensen, K.B., Jin, P., Brown, V., Warren, S.T., and Darnell, R.B. 2001. Fragile X mental retardation protein targets G Quartet mRNAs important for neuronal function. Cell 107: 489-499.
19. Darnell, J.C., Mostovetsky, O. and Darnell, R.B. 2005. FMRP RNA targets: Identification and validation. Genes, Brain and Behavior (in press).
20. DeBoulle, K., Verkerk, A., Reyniers, E., Vits, L., Hendrickx, J., Van Roy, B., Van Den Bos, F., de Graaff, E., Oostra, B., and Willems, P. 1993. A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat. Genet. 3: 31-35.
21. Dowell, R.D. and Eddy, S.R. 2004. Evaluation of several light-weight stochastic context-free grammars for RNA secondary structure prediction. BMC Bioinformatics 5: 71.
22. Draper, D.E. 2004. A guide to ions and RNA structure. RNA 10: 335-343.
23. Dredge, B.K. and Darnell, R.B. 2003. Nova regulates GABA(A) receptor γ2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer. Mol. Cell. Biol. 23: 4687-4700.
24. Ehresmann, C., Baudin, F., Mougel, M., Romby, P., Ebel, J.P., and Ehresmann, B. 1987. Probing the structure of RNAs in solution. Nucleic Acids Res. 15: 9109-9128.
25. Ellington, A. and Szostak, J. 1990. In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822.
26. Farina, K.L., Huttelmaier, S., Musunuru, K., Darnell, R.B., and Singer, R.H. 2003. Two ZBP1 KH domains facilitate β-actin mRNA localization, granule formation, and cytoskeletal attachment. J. Cell Biol. 160: 77-87.
27. Feng, Y., Absher, D., Eberhart, D.E., Brown, V., Malter, H.E., and Warren, S.T. 1997a. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell 1: 109-118.
28. Feng, Y., Gutekunst, C.A., Eberhart, D.E., Yi, H., Warren, S.T., and Hersch, S.M. 1997b. Fragile X mental retardation protein-nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J. Neurosci. 17: 1539-1547.
29. Ferrandon, D., Koch, L, Westhof, E., and Nusslein-Volhard, C. 1997. RNA-RNA interaction is required for the formation of specific bicoid mRNA 3′ UTR-STAUFEN ribonucleoprotein particles. EMBO J. 16: 1751-1758.
30. Gabus, C., Mazroui, R., Tremblay, S., Khandjian, E.W., and Darlix, J.L. 2004. The fragile X mental retardation protein has nucleic acid chaperone properties. Nucleic Acids Res. 32: 2129-2137.
31. Gallouzi, I.E., Brennan, C.M., Stenberg, M.G., Swanson, M.S., Eversole, A., Maizels, N., and Steitz, J.A. 2000. HuR binding to cytoplasmic mRNA is perturbed by heat shock. Proc. Natl. Acad. Sci. 97: 3073-3078.
32. Gao, F.B. 2002. Understanding fragile X syndrome: Insights from retarded flies. Neuron 34: 859-862.
33. Greenough, W.T., Klintsova, A.Y., Irwin, S.A., Galvez, R., Bates, K.E., and Weiler, I.J. 2001. Synaptic regulation of protein synthesis and the fragile X protein. Proc. Natl. Acad. Sci. 98: 7101-7106.
34. Gutell, R.R., Lee, J.C., and Cannone, J.J. 2002. The accuracy of ribosomal RNA comparative structure models. Curr. Opin. Struct. Biol. 12: 301-310.
35. Ishizuka, A., Siomi, M.C., and Siomi, H. 2002. A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes & Dev. 16: 2497-2508.
36. Jensen, K.B., Dredge, B.K., Stefani, G., Zhong, R., Buckanovich, R.J., Okano, H.J., Yang, Y.Y., and Darnell, R.B. 2000a. Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron 25: 359-371.
37. Jensen, K.B., Musunuru, K., Lewis, H.A., Burley, S.K., and Darnell, R.B. 2000b. The tetranucleotide UCAY directs the specific recognition of RNA by the Nova KH3 domain. Proc. Natl. Acad. Sci. 97: 5740-5745.
38. Jin, P. and Warren, S.T. 2003. New insights into fragile X syndrome: From molecules to neurobehaviors. Trends Biochem. Sci. 28: 152-158.
39. Jin, P., Zarnescu, D.C., Ceman, S., Nakamoto, M., Mowrey, J., Jongens, T.A., Nelson, D.L., Moses, K., and Warren, S.T. 2004. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat. Neurosci. 7: 113-117.
40. Kaytor, M.D. and Orr, H.T. 2001. RNA targets of the fragile x protein. Cell 107: 555-557.
41. Khandjian, E.W., Corbin, F., Woerly, S., and Rousseau, F. 1996. The fragile X mental retardation protein is associated with ribosomes. Nat. Genet. 12: 91-93.
42. Khandjian, E.W., Huot, M.E., Tremblay, S., Davidovic, L., Mazroui, R., and Bardoni, B. 2004. Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles. Proc. Natl. Acad. Sci. 101: 13357-13362.
43. Kim, S.H., Suddath, F.L., Quigley, G.J., McPherson, A., Sussman, J.L., Wang, A.H., Seeman, N.C., and Rich, A. 1974. Three-dimensional tertiary structure of yeast phenylalanine transfer RNA. Science 185: 435-440.
44. Kislauskis, E.H., Li, Z., Singer, R.H., and Taneja, K.L. 1993. Isoform-specific 3′-untranslated sequences sort α-cardiac and β-cytoplasmic actin messenger RNAs to different cytoplasmic compartments. J. Cell Biol. 123: 165-172.
45. Kolb, P.A., Engdahl, H.M., Slagter-Jager, J.G., Ehresmann, B., Ehresmann, C., Westhof, E., Wagner, E.G., and Romby, P. 2000a. Progression of a loop-loop complex to a four-way junction is crucial for the activity of a regulatory antisense RNA. EMBO J. 19: 5905-5915.
46. Kolb, F.A., Malmgren, C., Westhof, E., Ehresmann, C., Ehresmann, B., Wagner, E.G., and Romby, P. 2000b. An unusual structure formed by antisense-target RNA binding involves an extended kissing complex with a four-way junction and a side-by-side helical alignment. RNA 6: 311-324.
47. Laggerbauer, B., Ostareck, D., Keidel, E.M., Ostareck-Lederer, A., and Fischer, U. 2001. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 10: 329-338.
48. Lewis, H.A., Chen, H., Edo, C., Buckanovich, R.J., Yang, Y.Y., Musunuru, K., Zhong, R., Darnell, R.B., and Burley, S.K. 1999. Crystal structures of Nova-1 and Nova-2 K-homology RNA-binding domains. Structure 7: 191-203.
49. Lewis, H.A., Musunuru, K., Jensen, K.B., Edo, C., Chen, H., Darnell, R.B., and Burley, S.K. 2000. Sequence-specific RNA binding by a Nova KH domain: Implications for paraneoplastic disease and the fragile X syndrome. Cell 100: 323-332.
50. Liu, Z., Luyten, I., Bottomley, M.J., Messias, A.C., Houngninou-Molango, S., Sprangers, R., Zanier, K., Kramer, A., and Sattler, M. 2001. Structural basis for recognition of the intron branch site RNA by splicing factor 1. Science 294: 1098-1102.
51. Mathews, D.H., Sabina, J., Zuker, M., and Turner, D.H. 1999. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J. Mol. Biol. 288: 911-940.
52. Mazroui, R., Huot, M.E., Tremblay, S., Filion, C., Labelle, Y., and Khandjian, E.W. 2002. Trapping of messenger RNA by Fragile X Mental Retardation protein into cytoplasmic granules induces translation repression. Hum. Mol. Genet. 11: 3007-3017.
53. Mazroui, R., Huot, M.E., Tremblay, S., Boilard, N., Labelle, Y., and Khandjian, E.W. 2003. Fragile X Mental Retardation protein determinants required for its association with polyribosomal mRNPs. Hum. Mol. Genet. 12: 3087-3096.
54. Miyashiro, K.Y., Beckel-Mitchener, A., Purk, T.P., Becker, K.G., Barret, T., Liu, L., Carbonetto, S., Weiler, I.J., Greenough, W.T., and Eberwine, J. 2003. RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 37: 417-431.
55. Moras, D., Comarmond, M.B., Fischer, J., Weiss, R., Thierry, J.C., Ebel, J.P., and Giege, R. 1980. Crystal structure of yeast tRNAAsp. Nature 288: 669-674.
56. Musco, G., Stier, G., Joseph, C., Morelli, M.A.C., Nilges, M., Gibson, T., and Pastore, A. 1996. Three-dimensional structure and stability of the KH domain: Molecular insights into the Fragile X syndrome. Cell 85: 237-245.
57. O'Donnell, W.T. and Warren, S.T. 2002. A decade of molecular studies of fragile X syndrome. Annu. Rev. Neurosci. 25: 315-338.
58. Ohashi, S., Koike, K., Omori, A., Ichinose, S., Ohara, S., Kobayashi, S., Sato, T.A., and Anzai, K. 2002. Identification of mRNA/protein (mRNP) complexes containing Purα, mStaufen, fragile X protein, and myosin Va and their association with rough endoplasmic reticulum equipped with a kinesin motor. J. Biol. Chem. 277: 37804-37810.
59. Okano, H.J. and Darnell, R.B. 1997. A hierarchy of Hu RNA binding proteins in developing and adult neurons. J. Neurosci. 17: 3024-3037.
60. Olejniczak, M., Gdaniec, Z., Fischer, A., Grabarkiewicz, T., Bielecki, L., and Adamiak, R.W. 2002. The bulge region of HIV-1 TAR RNA binds metal ions in solution. Nucleic Acids Res. 30: 4241-4249.
61. Ostareck, D.H., Ostarecklederer, A., Wilm, M., Thiele, B.J., Mann, M., and Hentze, M.W. 1997. mRNA silencing in erythroid differentiation-hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3′ end. Cell 89: 597-606.
62. Paillart, J.C., Marquet, R., Skripkin, E., Ehresmann, C., and Ehresmann, B. 1996a. Dimerization of retroviral genomic RNAs: Structural and functional implications. Biochimie 78: 639-653.
63. Paillart, J.C., Skripkin, E., Ehresmann, B., Ehresmann, C., and Marquet, R. 1996b. A loop-loop 'kissing' complex is the essential part of the dimer linkage of genomic HIV-1 RNA. Proc. Natl. Acad. Sci. 93:5572-5577.
64. Ramos, A., Hollingworth, D., and Pastore, A. 2003. The role of a clinically important mutation in the fold and RNA-binding properties of KH motifs. RNA 9: 293-298.
65. Rastogi, T., Beattie, T.L., Olive, J.E., and Collins, R.A. 1996. A long-range pseudoknot is required for activity of the Neurospora VS ribozyme. EMBO J. 15: 2820-2825.
66. Ross, A.F., Oleynikov, Y., Kislauskis, E.H., Taneja, K.L., and Singer, R.H. 1997. Characterization of a β-actin mRNA zipcode-binding protein. Mol. Cell. Biol. 17: 2158-2165.
67. Ryder, S.P., Prater, L.A., Abramovitz, D.L., Goodwin, E.B., and Williamson, J.R. 2004. RNA target specificity of the STAR/GSG domain post-transcriptional regulatory protein GLD-1. Nat. Struct. Mol. Biol. 11:20-28.
68. Schaeffer, C., Bardoni, B., Mandel, J.L., Ehresmann, B., Ehresmann, C., and Moine, H. 2001. The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. EMBO J. 20: 4803-4813.
69. Schenck, A., Bardoni, B., Moro, A., Bagni, C., and Mandel, J.L. 2001. A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Proc. Natl. Acad. Sci. 98: 8844-8849.
70. Siomi, H., Choi, M., Siomi, M., Nussbaum, R., and Dreyfuss, G. 1994. Essential role for KH domains in RNA binding: Impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 77: 33-39.
71. Stefani, G., Fraser, C.E., Darnell, J.C., and Darnell, R.B. 2004. Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells. J. Neurosci. 24: 9272-9276.
72. Thisted, T., Lyakhov, D.L., and Liebhaber, S.A. 2001. Optimized RNA targets of two closely related triple KH domain proteins, heterogeneous nuclear ribonucleoprotein K and α CP-2KL, suggest distinct modes of RNA recognition. J. Biol. Chem. 276: 17484-17496.
73. Todd, P.K., Mack, K.J., and Malter, J.S. 2003. The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95. Proc. Natl. Acad. Sci. 100: 14374-14378.
74. Tuerk, C. and Gold, L. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505-510.
75. Ule, J., Jensen, K.B., Ruggiu, M., Mele, A., Ule, A., and Darnell, R.B. 2003. CLIP identifies Nova-regulated RNA networks in the brain. Science 302: 1212-1215.
76. Villace, P., Marion, R.M., and Ortin, J. 2004. The composition of Staufen-containing RNA granules from human cells indicates their role in the regulated transport and translation of messenger RNAs. Nucleic Acids Res. 32: 2411-2420.
77. Yang, Y.Y.L., Yin, G.L., and Darnell, R.B. 1998. The neuronal RNA binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc. Natl. Acad. Sci. 95: 13254-13259.
78. Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., and Bagni, C. 2003. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 112: 317-327.
79. Zhang, Y.Q., Bailey, A.M., Matthies, H.J., Renden, R.B., Smith, M.A., Speese, S.D., Rubin, G.M., and Broadie, K. 2001. Drosophila fragile X-related gene regulates the MAP1B homolog futsch to control synaptic structure and function. Cell 107: 591-603.
80. Zuker, M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31: 3406-3415.